Received Dec 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | LA |
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | 7+ | — | LA |
Tested positive for COVID; Tested positive for COVID; This is a spontaneous report received from a consumer. An adult female patient (not pregnant) received BNT162b2 Omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 23Nov2025 at 15:30 as dose 1, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; influenza vaccine (FLU [INFLUENZA VACCINE]), on 23Nov2025 as dose 21, single, in left arm for immunisation. The patient's relevant medical history included: "Allergy to NSAIDs" (unspecified if ongoing). Concomitant medication(s) included: ABRYSVO taken for immunisation, on 23Nov2025 as dose 1, single. The patient also took other concomitant therapy. Vaccination history included: COVID-19 vaccine (DOSE 1, 2, 3, 4, and 5; MANUFACTURER UNKNOWN), for COVID-19 immunization; Influenza vaccine (DOSE 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, and 20; MANUFACTURER UNKNOWN), for Immunization. The patient took the 6th COVID-19 vaccine and 21st flu vaccine on 23Nov2025. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 11Dec2025, outcome "recovering" and all described as "Tested positive for COVID". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (11Dec2025) Positive. Therapeutic measures were taken as a result of the events which included Musinex (as reported) and TYLENOL.
Medical History/Concurrent Conditions: Allergy to NSAIDs
ABRYSVO
Test Date: 20251211; Test Name: SARS-CoV-2 test; Test Result: Positive